1. Home
  2. TXG vs SSII Comparison

TXG vs SSII Comparison

Compare TXG & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • SSII
  • Stock Information
  • Founded
  • TXG 2012
  • SSII N/A
  • Country
  • TXG United States
  • SSII India
  • Employees
  • TXG N/A
  • SSII N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • SSII
  • Sector
  • TXG Industrials
  • SSII
  • Exchange
  • TXG Nasdaq
  • SSII Nasdaq
  • Market Cap
  • TXG 1.6B
  • SSII 1.4B
  • IPO Year
  • TXG 2019
  • SSII N/A
  • Fundamental
  • Price
  • TXG $15.93
  • SSII $6.18
  • Analyst Decision
  • TXG Buy
  • SSII
  • Analyst Count
  • TXG 13
  • SSII 0
  • Target Price
  • TXG $14.50
  • SSII N/A
  • AVG Volume (30 Days)
  • TXG 3.2M
  • SSII 84.7K
  • Earning Date
  • TXG 11-06-2025
  • SSII 10-28-2025
  • Dividend Yield
  • TXG N/A
  • SSII N/A
  • EPS Growth
  • TXG N/A
  • SSII N/A
  • EPS
  • TXG N/A
  • SSII N/A
  • Revenue
  • TXG $641,814,000.00
  • SSII $36,066,457.00
  • Revenue This Year
  • TXG $2.07
  • SSII N/A
  • Revenue Next Year
  • TXG N/A
  • SSII N/A
  • P/E Ratio
  • TXG N/A
  • SSII N/A
  • Revenue Growth
  • TXG 1.92
  • SSII 158.36
  • 52 Week Low
  • TXG $6.78
  • SSII $2.48
  • 52 Week High
  • TXG $17.70
  • SSII $22.42
  • Technical
  • Relative Strength Index (RSI)
  • TXG 62.12
  • SSII 34.90
  • Support Level
  • TXG $12.80
  • SSII $6.58
  • Resistance Level
  • TXG $17.70
  • SSII $7.13
  • Average True Range (ATR)
  • TXG 0.97
  • SSII 0.60
  • MACD
  • TXG 0.30
  • SSII -0.26
  • Stochastic Oscillator
  • TXG 66.79
  • SSII 8.21

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About SSII SS Innovations International Inc.

SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.

Share on Social Networks: